Skip to main content

Advertisement

Table 8 Type of hormonal therapy administered according to menopausal status in 346 pT1a and pT1b tumours

From: Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

  Premenopausal (N = 89) Postmenopausal (N = 257)
Hormonal therapy   
Tamoxifen 5 y 11 (12.3%) 35 (13.6%)
Tamoxifen 5 y + LHRH 65 (73.0%) 0 (0.0%)
Tamoxifen 2-3y→Aromatase Inhibitor 3–2 y 3 (3.3%) 44 (17.1%)
Aromatase Inhibitor 5 y 1 (1.1%) 173 (67.3%)
Aromatase Inhibitor 5 y + LHRH 6 (6.7%) 1 (0.4%)
LHRH alone 1 (1.1%) 0 (0.0%)
Other 2 (2.2%) 4 (1.6%)